Cargando…

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy

Lymphocytosis is a marker of subcutaneous interleukin (IL)-2 therapy efficacy, whereas baseline elevated inflammatory indices were noticed in IL-2-resistant disease. The aim of this study was to analyse the relationship between pretreatment circulating values of IL-6, neopterin, sIL-2R, ESR and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fumagalli, L, Lissoni, P, Felice, G Di, Meregalli, S, Valsuani, G, Mengo, S, Rovelli, F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362330/ https://www.ncbi.nlm.nih.gov/pubmed/10408846 http://dx.doi.org/10.1038/sj.bjc.6690371

Ejemplares similares

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
por: Lissoni, P., et al.
Publicado: (1989)

Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
por: Lissoni, P., et al.
Publicado: (1990)

Pretreatment serum CRP and response to interleukin 2.
por: Blay, J. Y., et al.
Publicado: (1994)

In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients.
por: Lissoni, P., et al.
Publicado: (1998)

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.
por: Lissoni, P., et al.
Publicado: (1995)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
por: Zanetta, G, et al.
Publicado: (1999)

Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2
por: Heys, Steven D., et al.
Publicado: (1994)

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
por: Lissoni, P., et al.
Publicado: (1993)

Concordance of Immune-Related Markers in Lymphocytes and Prefrontal Cortex in Schizophrenia
por: Gatta, Eleonora, et al.
Publicado: (2021)

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
por: Lissoni, P., et al.
Publicado: (1994)

Alteration of tumour response to radiation by interleukin-2 gene transfer
por: Lee, J, et al.
Publicado: (2000)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2021)

Epstein–Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function
por: Axdorph, U, et al.
Publicado: (1999)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
por: Salgado, R, et al.
Publicado: (1999)

The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results
por: Lissoni, Paolo, et al.
Publicado: (2017)

Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer
por: Chang, Pei‐Hung, et al.
Publicado: (2016)

Washing Lime-Pretreated Rice Straw with Carbonated Water Facilitates Calcium Removal and Sugar Recovery in Subsequent Enzymatic Saccharification
por: Yamagishi, Kenji, et al.
Publicado: (2019)

Evaluation of Ammonia Pretreatment for Enzymatic Hydrolysis of Sugarcane Bagasse to Recover Xylooligosaccharides
por: Tsutsui, Sosyu, et al.
Publicado: (2020)

Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion
por: Kanai, T, et al.
Publicado: (2000)

Reusable Floating Beads with Immobilized Xylose-Fermenting Yeast Cells for Simultaneous Saccharification and Fermentation of Lime-Pretreated Rice Straw
por: Guan, Di, et al.
Publicado: (2019)

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
por: Lissoni, P., et al.
Publicado: (1992)

Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial
por: Kooten, M Van, et al.
Publicado: (1999)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000)

Increased radiosensitivity of melanoma cells through cold plasma pretreatment mediated by ICG
por: Momeni, Sara, et al.
Publicado: (2023)

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
por: Hazama, S, et al.
Publicado: (1999)

Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer
por: Prabawa, I Putu Yuda, et al.
Publicado: (2019)

Decrease in cholesterol levels during the immunotherapy of cancer with interleukin-2.
por: Lissoni, P., et al.
Publicado: (1991)

Serum levels of interleukin-6 and interleukin-8 as diagnostic markers of acute pyelonephritis in children
por: Mahyar, Abolfazl, et al.
Publicado: (2013)

Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2016)

Increased uracil misincorporation in lymphocytes from folate-deficient rats
por: Duthie, S J, et al.
Publicado: (2000)

Serum Tumor Marker Carbohydrate Antigen 125 Levels and Carotid Atherosclerosis in Patients with Coronary Artery Disease
por: Sang, Guo-Yao, et al.
Publicado: (2018)

Effects of different fluid replacements on serum HSP70 and lymphocyte DNA damage in college athletes during exercise at high ambient temperatures
por: Roh, Hee-Tae, et al.
Publicado: (2016)

Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder
por: Milella, M, et al.
Publicado: (1999)

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma
por: Fontanini, G, et al.
Publicado: (1999)

Serum Interleukin-15 is a Marker of Alopecia Areata Severity
por: Ebrahim, Adel Ali, et al.
Publicado: (2019)

Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes
Publicado: (1994)

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
por: Valero, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbhr9eqth9du6hp7c8drs2hgst